. 2022 Mar 7;13:845988. doi: 10.3389/fimmu.2022.845988
Copyright © 2022 Zuo, Ye, Chen, Shen, Lu, Wang and Shu
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Figure 2.
Risk factors of RP-ILD in patients with anti-ARS antibody.